Skip to main content

Table 2 Group comparisons of MRI-visible PVS and other MRI findings across the Alzheimer’s disease spectrum

From: Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer’s disease spectrum

 

Data available

CN

Data available

MCI

Data available

AD

p value

CSO-PVS grade

486

 

667

 

276

 

<0.001*,a,b,c

 No/mild (grades 0–1), n (%)

 

125 (25.7)

 

120 (18.0)

 

32 (11.6)

 

 Moderate (grade 2), n (%)

 

239 (49.2)

 

326 (48.9)

 

126 (45.7)

 

 Frequent/severe (grades 3–4), n (%)

 

122 (25.1)

 

221 (33.1)

 

118 (42.8)

 

 CSO-PVS number

 

15.9 (7.9)

 

17.5 (8.4)

 

19.0 (8.3)

<0.001*,a,b,c

BG-PVS grade

486

 

667

 

276

 

0.183

 No/mild (grades 0–1), n (%)

 

399 (82.1)

 

531 (79.6)

 

221 (80.1)

 

 Moderate (grade 2), n (%)

 

78 (16.0)

 

126 (18.9)

 

45 (16.3)

 

 Frequent/severe (grades 3–4), n (%)

 

9 (1.9)

 

10 (1.5)

 

10 (3.6)

 

 BG-PVS number

 

7.2 (4.1)

 

7.4 (4.1)

 

7.7 (4.8)

0.326

HP-PVS grade

486

 

667

 

276

 

0.432

 No/mild (0–1 PVS), n (%)

 

137 (28.2)

 

200 (30.0)

 

93 (33.7)

 

 Moderate (2–4 PVS), n (%)

 

217 (44.7)

 

290 (43.5)

 

122 (44.2)

 

 Frequent/severe (>4 PVS), n (%)

 

132 (27.2)

 

177 (26.5)

 

61 (22.1)

 

 HP-PVS number

 

3.2 (2.5)

 

3.0 (2.5)

 

2.8 (2.3)

0.182

WMH volume (cm3)

486

1.25 (0.25, 3.91)

666

0.79 (0.20, 3.28)

275

1.14 (0.24, 3.93)

0.057

HP volume (cm3)

483

7.33 (0.94)

653

6.57 (1.15)

262

5.60 (1.03)

<0.001*,a,b,c

Intracranial volume, cm3

486

1415 (138)

665

1442 (145)

276

1420 (157)

0.005*,a

  1. Values are reported as mean (standard deviation) for the quantitative variables except WMH volume which is reported as median (interquartile range). *p<0.05. Group comparisons were done with the one-way ANOVA (quantitative variables) and chi-square test (categorical variables). WMH volume was log-transformed for one-way ANOVA analysis. ap < 0.05 between CN vs MCI. bp < 0.05 between CN vs AD. cp < 0.05 between MCI vs AD. CN control, MCI mild cognitive impairment, AD Alzheimer disease, CSO centrum semiovale, BG basal ganglia, HP hippocampus, PVS perivascular spaces, WMH white matter hyperintensities